Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Pediatric Pulmonology|December 24, 2005
Measuring exhaled breath condensates in infantsAlexander Moeller, Peter Franklin, Graham L Hall, et al.
Current Medical Research and Opinion|January 6, 2006
Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacyFriedrich Horak, Ursula Petra Zieglmayer, René Zieglmayer, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivityJürgen Reisinger, Friedrich Horak, Gabrielle Pauli, et al.
Plos One|February 24, 2015
Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposureCornelia Egger, Christian Lupinek, Robin Ristl, et al.
International Archives of Allergy and Immunology|October 24, 2006
Antigens drive memory IgE responses in human allergy via the nasal mucosaVerena Niederberger, Johannes Ring, Jürgen Rakoski, et al.
Wiener Medizinische Wochenschrift (1946)|February 28, 2009
[Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]Isabella Pali-Schöll, Wolfgang Pohl, Werner Aberer, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2011
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitisAlain Didier, Margitta Worm, Friedrich Horak, et al.
Chest|March 26, 2009
Application of a shortened inhaled adenosine-5'-monophosphate challenge in young children using the forced oscillation techniqueGraham L Hall, Catherine Gangell, Takayoshi Fukushima, et al.
The Journal of Allergy and Clinical Immunology|October 16, 2007
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitisAlain Didier, Hans-Jörgen Malling, Margitta Worm, et al.
The Journal of Allergy and Clinical Immunology|February 27, 2016
Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitisFriedrich Horak, Kamal D Puri, Bart H Steiner, et al.
Pageof 6